References
- Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J. (2005). Cost of disorders of the brain in Europe Eur J Neurol, 12(Suppl. 1), 1–27.
- Banks WA. (2008). Developing drugs that can cross the blood-brain barrier: applications to Alzheimer’s disease. BMC Neurosci, 10(9 Suppl. 3), S2.
- Cerletti A, Drewe J, Fricker G, Eberle AN, Huwyler J. (2000). Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Target, 8, 435–446.
- Méresse S, Delbart C, Fruchart JC, Cecchelli R. (1989). Low-density lipoprotein receptor on endothelium of brain capillaries. J Neurochem, 53, 340–345.
- de Boer AG, Gaillard PJ. (2007). Drug targeting to the brain. Annu Rev Pharmacol Toxicol, 47, 323–355.
- Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R. (1997). A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol, 138, 877–889.
- Dunay IR, Heimesaat MM, Bushrab FN, Müller RH, Stocker H, Arasteh K, Kurowski M, Fitzner R, Borner K, Liesenfeld O. (2004). Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother, 48, 4848–4854.
- Foerg C, Merkle HP. (2008). On the biomedical promise of cell penetrating peptides: limits versus prospects. J Pharm Sci, 97, 144–1462.
- Fricker G, Nobmann S, Miller DS. (2002). Permeability of porcine blood brain barrier to somatostatin analogues. Br J Pharmacol, 135, 1308–1314.
- Huwyler J, Pardridge WM. (1998). Examination of blood-brain barrier transferrin receptor by confocal fluorescent microscopy of unfixed isolated rat brain capillaries. J Neurochem, 70, 883–886.
- Huwyler J, Yang J, Pardridge WM. (1997) Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther, 282, 1541–1546.
- Huwyler J, Wu D, Pardridge WM. (1996). Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA, 93, 14164–14169.
- Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev, 47, 65–81.
- Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. (2002). Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target, 10, 317–325.
- Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY. (1984). Transferrin receptor on endothelium of brain capillaries. Nature, 312, 162–163.
- Lee DS, Griffiths BW. (1984). Comparative studies of Iodo-bead and chloramine-T methods for the radioiodination of human alpha-fetoprotein. J Immunol Meth, 74, 181–189.
- Pardridge WM. (2006). Molecular trojan horses for blood-brain barrier drug delivery. Discov Med, 6, 139–143.
- Pardridge WM. (2007). Drug targeting to the brain. Pharm Res, 24(9), 1733–1744.
- Reimold I, Domke D, Bender J, Seyfried CA, Radunz HE, Fricker G. (2008). Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm, 70, 627–632.
- Rousselle C, Clair P, Lefauconnier JM, Kaczorek M, Scherrmann JM, Temsamani J. (2000). New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol, 57, 679–686.
- Rousselle C, Smirnova M, Clair P, Lefauconnier JM, Chavanieu A, Calas B, Scherrmann JM, Temsamani J. (2001). Enhanced delivery of doxorubicin into the brain via a peptide-vector mediated strategy: saturation kinetics and specificity. J Pharmacol Exp Ther, 296, 124–131.
- Shamenkov DA, Petrov VE, Alyautdin RN. (2006). Effects of apolipoproteins on dalargin transport across the blood-brain barrier. Bull Exp Biol Med, 142, 703–706.
- Schöler N, Krause K, Kayser O, Müller RH, Borner K, Hahn H, Liesenfeld O. (2001). Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother, 45, 1771–1779.
- Thöle M, Nobmann S, Huwyler J, Bartmann A, Fricker G. (2002). Uptake of cationized albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries. J Drug Target, 10, 337–344.
- Visser CC, Stevanović S, Heleen Voorwinden L, Gaillard PJ, Crommelin DJ, Danhof M, De Boer AG. (2004). Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J Drug Target, 12, 145–150.
- Wu D, Yang J, Pardridge WM. (1997). Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J Clin Invest, 100, 1804–1812.